| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
A Cancer Diary
|
Burki, Talha Khan
|
|
2017
|
18 |
2 |
p. 177-
1 p.
|
article
|
| 2 |
Adjuvant chemotherapy for upper tract urothelial cancer
|
Tanday, Sanjay
|
|
2017
|
18 |
2 |
p. e73-
1 p.
|
article
|
| 3 |
Advanced colorectal cancer treatment options beyond standard systemic therapy
|
Price, Timothy J
|
|
2017
|
18 |
2 |
p. 157-159
3 p.
|
article
|
| 4 |
Advancing access and equity: the vision of a new generation in cancer control
|
Ilbawi, André M
|
|
2017
|
18 |
2 |
p. 172-175
4 p.
|
article
|
| 5 |
A genome-based model for adjusting radiotherapy dose (GARD): a retrospective, cohort-based study
|
Scott, Jacob G
|
|
2017
|
18 |
2 |
p. 202-211
10 p.
|
article
|
| 6 |
Another piece in the jigsaw of accelerated partial breast irradiation
|
Coles, Charlotte E
|
|
2017
|
18 |
2 |
p. 168-169
2 p.
|
article
|
| 7 |
A Series of Catastrophes and Miracles
|
Kennedy, Anna
|
|
2017
|
18 |
2 |
p. 178-
1 p.
|
article
|
| 8 |
Cetuximab chemoradiotherapy in HIV-associated anal cancer
|
Das, Manjulika
|
|
2017
|
18 |
2 |
p. e67-
1 p.
|
article
|
| 9 |
Checkpoint inhibition: a new beginning for urothelial cancer
|
Rose, Tracy L
|
|
2017
|
18 |
2 |
p. 160-161
2 p.
|
article
|
| 10 |
China's health trajectory in 2017
|
The Lancet Oncology,
|
|
2017
|
18 |
2 |
p. 155-
1 p.
|
article
|
| 11 |
Chronic lymphocytic leukaemia: a step ahead in the journey toward eradication
|
De Paoli, Lorenzo
|
|
2017
|
18 |
2 |
p. 163-164
2 p.
|
article
|
| 12 |
Consolidative local therapy in oligometastatic patients
|
Kim, Chul
|
|
2017
|
18 |
2 |
p. e61-
1 p.
|
article
|
| 13 |
Consolidative local therapy in oligometastatic patients
|
Alongi, Filippo
|
|
2017
|
18 |
2 |
p. e60-
1 p.
|
article
|
| 14 |
Consolidative local therapy in oligometastatic patients – Authors' reply
|
Gomez, Daniel
|
|
2017
|
18 |
2 |
p. e62-
1 p.
|
article
|
| 15 |
Correction to Lancet Oncol 2017; 18: 205, 206, 208, 210
|
|
|
2017
|
18 |
2 |
p. e65-
1 p.
|
article
|
| 16 |
Definitions of oesophageal cancer
|
Burki, Talha Khan
|
|
2017
|
18 |
2 |
p. e71-
1 p.
|
article
|
| 17 |
Generic drugs in oncology
|
Levêque, Dominique
|
|
2017
|
18 |
2 |
p. e63-
1 p.
|
article
|
| 18 |
Generic drugs in oncology – Authors' reply
|
Bennett, Charles L
|
|
2017
|
18 |
2 |
p. e64-
1 p.
|
article
|
| 19 |
Histiocytoses: emerging neoplasia behind inflammation
|
Haroche, Julien
|
|
2017
|
18 |
2 |
p. e113-e125
nvt p.
|
article
|
| 20 |
Ibrutinib for patients with rituximab-refractory Waldenström's macroglobulinaemia (iNNOVATE): an open-label substudy of an international, multicentre, phase 3 trial
|
Dimopoulos, Meletios A
|
|
2017
|
18 |
2 |
p. 241-250
10 p.
|
article
|
| 21 |
Ibrutinib in Waldenström's macroglobulinemia: revamping the landscape
|
Cheson, Bruce D David
|
|
2017
|
18 |
2 |
p. 165-166
2 p.
|
article
|
| 22 |
ImmunoScore predicts gastric cancer postsurgical outcome
|
Wang, Mai
|
|
2017
|
18 |
2 |
p. e68-
1 p.
|
article
|
| 23 |
Is a negative prostate biopsy a risk factor for a prostate cancer related death?
|
Emberton, Mark
|
|
2017
|
18 |
2 |
p. 162-163
2 p.
|
article
|
| 24 |
Just in the Nip of Time
|
Tang, Paul Kiet
|
|
2017
|
18 |
2 |
p. 180-
1 p.
|
article
|
| 25 |
Late side-effects and cosmetic results of accelerated partial breast irradiation with interstitial brachytherapy versus whole-breast irradiation after breast-conserving surgery for low-risk invasive and in-situ carcinoma of the female breast: 5-year results of a randomised, controlled, phase 3 trial
|
Polgár, Csaba
|
|
2017
|
18 |
2 |
p. 259-268
10 p.
|
article
|
| 26 |
Long interval zoledronic acid use in bone metastases
|
Das, Manjulika
|
|
2017
|
18 |
2 |
p. e72-
1 p.
|
article
|
| 27 |
Low-risk prostate cancer: to treat or not to treat
|
Freedland, Stephen J
|
|
2017
|
18 |
2 |
p. 156-157
2 p.
|
article
|
| 28 |
177Lu-Dotatate for midgut neuroendocrine tumours
|
Burki, Talha Khan
|
|
2017
|
18 |
2 |
p. e74-
1 p.
|
article
|
| 29 |
MABp1 as a novel antibody treatment for advanced colorectal cancer: a randomised, double-blind, placebo-controlled, phase 3 study
|
Hickish, Tamas
|
|
2017
|
18 |
2 |
p. 192-201
10 p.
|
article
|
| 30 |
Malignancy-associated haemophagocytic lymphohistiocytosis in adults
|
Daver, Naval
|
|
2017
|
18 |
2 |
p. 169-171
3 p.
|
article
|
| 31 |
Non-transplant therapies for patients with hepatocellular carcinoma and Child-Pugh-Turcotte class B cirrhosis
|
Granito, Alessandro
|
|
2017
|
18 |
2 |
p. e101-e112
nvt p.
|
article
|
| 32 |
Onartuzumab ineffective in non-small-cell lung cancer
|
Brower, Vicki
|
|
2017
|
18 |
2 |
p. e66-
1 p.
|
article
|
| 33 |
One-stage versus two-stage breast reconstruction: prudence in surgical decision-making
|
Gougoutas, Alexander J
|
|
2017
|
18 |
2 |
p. 166-167
2 p.
|
article
|
| 34 |
Our Faustian pact with the digital world
|
McNeil, Catriona M
|
|
2017
|
18 |
2 |
p. 171-172
2 p.
|
article
|
| 35 |
Our Lady of Tumours
|
Riva, Michele A
|
|
2017
|
18 |
2 |
p. 180-
1 p.
|
article
|
| 36 |
Padeliporfin vascular-targeted photodynamic therapy versus active surveillance in men with low-risk prostate cancer (CLIN1001 PCM301): an open-label, phase 3, randomised controlled trial
|
Azzouzi, Abdel-Rahmène
|
|
2017
|
18 |
2 |
p. 181-191
11 p.
|
article
|
| 37 |
Pioglitazone with imatinib in CML may reduce residual disease
|
Brower, Vicki
|
|
2017
|
18 |
2 |
p. e70-
1 p.
|
article
|
| 38 |
Prevention of radiotherapy-induced neurocognitive dysfunction in survivors of paediatric brain tumours: the potential role of modern imaging and radiotherapy techniques
|
Ajithkumar, Thankamma
|
|
2017
|
18 |
2 |
p. e91-e100
nvt p.
|
article
|
| 39 |
Radiation oncology enters the era of individualised medicine
|
Poortmans, Philip
|
|
2017
|
18 |
2 |
p. 159-160
2 p.
|
article
|
| 40 |
Recommendations for gonadotoxicity surveillance in male childhood, adolescent, and young adult cancer survivors: a report from the International Late Effects of Childhood Cancer Guideline Harmonization Group in collaboration with the PanCareSurFup Consortium
|
Skinner, Roderick
|
|
2017
|
18 |
2 |
p. e75-e90
nvt p.
|
article
|
| 41 |
Risk of prostate cancer diagnosis and mortality in men with a benign initial transrectal ultrasound-guided biopsy set: a population-based study
|
Klemann, Nina
|
|
2017
|
18 |
2 |
p. 221-229
9 p.
|
article
|
| 42 |
Safety and activity of pembrolizumab in patients with locally advanced or metastatic urothelial cancer (KEYNOTE-012): a non-randomised, open-label, phase 1b study
|
Plimack, Elizabeth R
|
|
2017
|
18 |
2 |
p. 212-220
9 p.
|
article
|
| 43 |
San Antonio Breast Cancer Symposium 2016
|
Gourd, Katherine
|
|
2017
|
18 |
2 |
p. 176-
1 p.
|
article
|
| 44 |
Selumetinib for children with plexiform neurofibromas
|
Burki, Talha Khan
|
|
2017
|
18 |
2 |
p. e69-
1 p.
|
article
|
| 45 |
The Chemo Files: one year on
|
Swain, Kelley
|
|
2017
|
18 |
2 |
p. 179-
1 p.
|
article
|
| 46 |
The Radium Girls
|
Burki, Talha Khan
|
|
2017
|
18 |
2 |
p. 178-
1 p.
|
article
|
| 47 |
Tumoral calcinosis of the shoulder
|
Megaloikonomos, Panayiotis D
|
|
2017
|
18 |
2 |
p. e126-
1 p.
|
article
|
| 48 |
Two-stage implant-based breast reconstruction compared with immediate one-stage implant-based breast reconstruction augmented with an acellular dermal matrix: an open-label, phase 4, multicentre, randomised, controlled trial
|
Dikmans, Rieky E G
|
|
2017
|
18 |
2 |
p. 251-258
8 p.
|
article
|
| 49 |
Venetoclax plus rituximab in relapsed or refractory chronic lymphocytic leukaemia: a phase 1b study
|
Seymour, John F
|
|
2017
|
18 |
2 |
p. 230-240
11 p.
|
article
|
Journal description